Brief: Mankind Pharma Buys Remaining 10% Stake In Upakarma
02/06/2026 13:35
BRIEF-Mankind Pharma Buys Remaining 10% Stake In Upakarma June 2 (Reuters) - Mankind Pharma Ltd MNKI.NS:
UNIT BUYS REMAINING 10% STAKE IN UPAKARMA
ACQUISITION COST FOR 10% STAKE IN UPAKARMA IS 7.5 MILLION RUPEES
Source text: ID:nBSE97jdLy
Further company coverage: MNKI.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mankind Pharma
See all newsIndia's Mankind Pharma heads for best day in over 3 years as Q2 hints at recovery
Mankind Pharma's quarterly profit jumps 39% on strong chronic drug demand
India's Mankind Pharma gains on higher quarterly profit
Brief: Mankind Pharma Says To Buy 70% Majority Stake In Armed Cell Therapeutics Through Unit
Kotak upgrades India's Mankind Pharma to 'buy' on signs of business recovery